首页> 美国卫生研究院文献>Nucleic Acids Research >The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases
【2h】

The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases

机译:黑暗激酶知识库:一个在线知识和实验结果的在线统计学结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Kinases form the backbone of numerous cell signaling pathways, with their dysfunction similarly implicated in multiple pathologies. Further facilitated by their druggability, kinases are a major focus of therapeutic development efforts in diseases such as cancer, infectious disease and autoimmune disorders. While their importance is clear, the role or biological function of nearly one-third of kinases is largely unknown. Here, we describe a data resource, the Dark Kinase Knowledgebase (DKK; https://darkkinome.org), that is specifically focused on providing data and reagents for these understudied kinases to the broader research community. Supported through NIH’s Illuminating the Druggable Genome (IDG) Program, the DKK is focused on data and knowledge generation for 162 poorly studied or ‘dark’ kinases. Types of data provided through the DKK include parallel reaction monitoring (PRM) peptides for quantitative proteomics, protein interactions, NanoBRET reagents, and kinase-specific compounds. Higher-level data is similarly being generated and consolidated such as tissue gene expression profiles and, longer-term, functional relationships derived through perturbation studies. Associated web tools that help investigators interrogate both internal and external data are also provided through the site. As an evolving resource, the DKK seeks to continually support and enhance knowledge on these potentially high-impact druggable targets.
机译:激酶形成许多细胞信号传导途径的骨干,其功能障碍类似地涉及多种病理学。通过其可耐药性进一步促进,激酶是癌症,传染病和自身免疫障碍等疾病中治疗发展努力的主要焦点。虽然他们的重要性很清楚,但近三分之一的激酶的作用或生物学功能在很大程度上是未知的。在这里,我们描述了一个数据资源,黑暗激酶知识库(DKK; HTTPS://Darkkinome.org),专门专注于为这些被认为是更广泛的研究界提供这些被认为的水酶的数据和试剂。通过NIH的阐明可药物基因组(IDG)程序,DKK专注于数据和知识生成162种差读或“黑暗”激酶。通过DKK提供的数据类型包括用于定量蛋白质组学,蛋白质相互作用,纳米多元试剂和激酶特异性化合物的平行反应监测(PRM)肽。类似地产生和整合诸如组织基因表达谱的诸如组织基因表达谱的较高级别的数据以及通过扰动研究来源的长期功能关系。通过该网站还提供了帮助调查人员询问内部和外部数据的相关网络工具。作为一种不断发展的资源,DKK旨在不断支持和提高这些潜在的高抗可药物目标的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号